BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Celgene International Sárl Release: Study Evaluating REVLIMID® Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at American Society of Clinical Oncology

  June 3, 2013

   · 

  1 min read
• Business

  Precision Engineered Products Names Head of Wauconda Business Unit

  June 3, 2013

   · 

  1 min read
• Business

  PTC Therapeutics, Inc. Appoints Shane Kovacs as Chief Financial Officer

  June 3, 2013

   · 

  2 min read
• Proventix to Attend APIC, Congratulates Clients for APIC Abstract and Poster Presentations

  June 3, 2013

   · 

  2 min read
• Deals

  Hyperion Therapeutics Acquires Worldwide Rights to BUPHENYL

  June 3, 2013

   · 

  1 min read
• Drug Development

  EXINI and Active Biotech AB Present Impact of Tasquinimod on Bone Metastases as Measured by Bone Scan Index (BSI)

  June 3, 2013

   · 

  1 min read
• Drug Development

  TG Therapeutics, Inc. Announces Presentation of Interim Results From Its Phase I/II Clinical Trial of Single-Agent Ublituximab (TG-1101) in Patients With Rituximab Relapsed/Refractory Non-Hodgkin’s Lymphoma

  June 3, 2013

   · 

  1 min read
• Genetown

  Inform Genomics Presents Biologic Validity for OnPART Predictive Networks Identifying Potential Genomic Targets for Drug Discovery

  June 3, 2013

   · 

  1 min read
• Business

  Agendia Appoints Peter W. Schineller as Chief Commercial Officer

  June 3, 2013

   · 

  2 min read
• Allied’s CardioCel® $1.9 Million Grant From Commercialisation Australia

  June 3, 2013

   · 

  4 min read